Heart disease is the number one cause of death for both men and women in the United States, claiming approximately 1 million lives per year. Heart attacks alone strike someone every 43 seconds. On January 20, 2014, that someone was Preston Anderson, a former stand-out Duke football player and otherwise active, healthy individual. Watch the video to hear his story and learn how life-changing medical technology saved Preston’s life.
Cantel Medical Names Jorgen B. Hansen as New President and CEO
LITTLE FALLS, New Jersey, (August 1, 2016) – CANTEL MEDICAL CORP.
(NYSE:CMN) announced today the appointment of Jorgen B. Hansen as the Company’s President and Chief Executive Officer, effective today, consistent with the Company’s long-term CEO succession plan. Mr. Hansen also will become a member of the Board of Directors. Mr. Hansen succeeds Andrew A. Krakauer, who will serve as a Senior Advisor for the Company until October 15, 2016.
Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to begin a prospective, multicenter, randomized clinical trial for its Sylys® Surgical Sealant device.
Ex-Duke football player: How I had my heart attack (and what you can learn from it)
Heart disease is the number one cause of death for both men and women in the United States. Claiming approximately 1 million lives per year, heart attacks alone strike someone every 43 seconds. On January 20, 2014, that someone was me.
To manage chronic pain, use the whole toolkit, not just opioids
Opioid addiction, abuse, and overdose are at the forefront of our national dialogue. But by casting opioids as the villain, this important conversation is missing an essential element: how best to treat the chronic pain that afflicts 100 million Americans, including many of our wounded warriors. Chronic pain is a multifaceted problem with a range of causes and solutions, not a two-dimensional condition that can only be treated with opioids.
FDA approves Raindrop presbyopia inlay from ReVision Optics
ReVision Optics won pre-market approval from the FDA yesterday for its Raindrop near vision inlay, a corneal implant designed to treat presbyopia.The Raindrop is a microscopic hydrogel inlay placed in the cornea of the patient’s non-dominant eye during a 10-minute procedure to gently reshape the anterior curvature of the cornea to provide near and intermediate vision, Lake Forest, Calif.-based ReVision said.